VOYA Investment Management
FDMT icon

VOYA Investment Management’s 4D Molecular Therapeutics FDMT Stock Holding History

VOYA Investment Management’s Portfolio FDMT Stock Details FDMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.86M Buy
140,200
+94,841
+209% +$924K ﹤0.01% 1266
2026
Q1 		$422K Buy
+45,359
New +$395K ﹤0.01% 1804
2025
Q3 		– Sell
-12,797
Closed -$47.5K – 2514
2025
Q2 		$47.5K Sell
12,797
-1,703
-12% -$5.99K ﹤0.01% 2613
2025
Q1 		$46.8K Sell
14,500
-1,006
-6% -$4.74K ﹤0.01% 2557
2024
Q4 		$86.4K Sell
15,506
-933
-6% -$7.32K ﹤0.01% 2604
2024
Q3 		$178K Sell
16,439
-313
-2% -$5.19K ﹤0.01% 2517
2024
Q2 		$352K Buy
16,752
+3,481
+26% +$87.3K ﹤0.01% 2188
2024
Q1 		$423K Sell
13,271
-2,609
-16% -$66.6K ﹤0.01% 2090
2023
Q4 		$322K Hold
15,880
– – ﹤0.01% 2306
2023
Q3 		$202K Buy
15,880
+3,294
+26% +$55.1K ﹤0.01% 2537
2023
Q2 		$227K Buy
12,586
+876
+7% +$16.1K ﹤0.01% 2521
2023
Q1 		$201K Hold
11,710
– – ﹤0.01% 2536
2022
Q4 		$260K Hold
11,710
– – ﹤0.01% 2424
2022
Q3 		$94.1K Hold
11,710
– – ﹤0.01% 2791
2022
Q2 		$82K Buy
11,710
+1,184
+11% +$11.5K ﹤0.01% 2661
2022
Q1 		$159K Buy
10,526
+1,242
+13% +$19.5K ﹤0.01% 2426
2021
Q4 		$204K Buy
9,284
+1,134
+14% +$27.8K ﹤0.01% 2502
2021
Q3 		$220K Buy
+8,150
New +$232K ﹤0.01% 2515

Other funds holding FDMT

JT
Jupiter Topco New York $245B AUM
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM

VOYA Investment Management's FDMT Position: Q2 2026 in Review

VOYA Investment Management increased its 4D Molecular Therapeutics (FDMT) stake by 209% in Q2 2026, buying an estimated $924K and bringing the position to 140,200 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

VOYA Investment Management first reported a position in FDMT in Q3 2021 and has held it in 18 quarters since. 158 funds tracked by Wall St. Rank hold FDMT as of Q2 2026.

  • VOYA Investment Management held 140,200 shares of 4D Molecular Therapeutics worth $1.86M as of Q2 2026.
  • VOYA Investment Management bought 94,841 4D Molecular Therapeutics shares in Q2 2026, an estimated $924K.
  • 4D Molecular Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1266 holding.
  • VOYA Investment Management first reported a position in 4D Molecular Therapeutics in Q3 2021 and has held it in 18 quarters since.
  • 158 funds tracked by Wall St. Rank held 4D Molecular Therapeutics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.